Walleye Capital
CLMT icon

Walleye Capital’s Calumet Specialty Products CLMT Stock Holding History

Walleye Capital’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Buy
4,600
+3,100
+207% +$104K ﹤0.01% 3608
2026
Q1 		$53.9K Sell
1,500
-9,200
-86% -$238K ﹤0.01% 3884
2025
Q4 		$213K Sell
10,700
-36,900
-78% -$710K ﹤0.01% 3514
2025
Q3 		$869K Sell
47,600
-28,000
-37% -$461K ﹤0.01% 2199
2025
Q2 		$1.19M Buy
75,600
+51,600
+215% +$656K ﹤0.01% 1909
2025
Q1 		$304K Buy
+24,000
New +$377K ﹤0.01% 2945

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Walleye Capital's CLMT Position: Q2 2026 in Review

Walleye Capital reduced its Calumet Specialty Products (CLMT) stake by 91% in Q2 2026, selling an estimated $10.2M and leaving 31,915 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

Walleye Capital first reported a position in CLMT in Q4 2019 and has held it in 6 quarters since. The position peaked at $12.1M in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Walleye Capital held 31,915 shares of Calumet Specialty Products worth $1.15M as of Q2 2026.
  • Walleye Capital sold 304,281 Calumet Specialty Products shares in Q2 2026, an estimated $10.2M.
  • Calumet Specialty Products made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #1996 holding.
  • Walleye Capital first reported a position in Calumet Specialty Products in Q4 2019 and has held it in 6 quarters since.
  • Walleye Capital's Calumet Specialty Products position peaked at $12.1M in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.